Publication |
Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19. Weiss LJ, Drayss M, Manukjan G, Zeitlhöfler M, Kleiss J, Weigel M, Herrmann J, Mott K, Beck S, Burkard P, Lâm TT, Althaus K, Bakchoul T, Frantz S, Meybohm P, Nieswandt B, Weismann D, Schulze H. Blood Adv. 2023 Jun 13;7(11):2324-2338. doi: 10.1182/bloodadvances.2022008666.
|
Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis. Weiss LJ, Manukjan G, Pflug A, Winter N, Weigel M, Nagler N, Kredel M, Lâm TT, Nieswandt B, Weismann D, Schulze H. Blood. 2021 Jun 3;137(22):3105-3115. doi: 10.1182/blood.2020009774.
|
|
| Last update Publications 03.09.2022 |
|